Kevin Tang, Director at Aurinia Pharmaceuticals Inc. (AUPH), bought 1,200,000 shares at $8.91 ($10.8M) on 2024-12-05, disclosed to the SEC on 2024-12-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.91 | 300,000 | $2.7M | 24.7% |
| 2 | $9.01 | 400,000 | $3.6M | 33.3% |
| 3 | $9.09 | 500,000 | $4.5M | 42.0% |
| Total | $9.02 avg | 1,200,000 | $10.8M | 100% |
| Filing → |
| FULC | BUY | 2026-07-20 | $595K | — | Filing → |
| BOLD | BUY | 2026-07-16 | $156K | — | Filing → |
| FULC | BUY | 2026-07-15 | $891K | — | Filing → |